 | • レポートコード：QYR9N7624 • 出版社/出版日：QYResearch / 2019年6月14日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（受注後２～3営業日） • 産業分類：医療・製薬・バイオ |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当資料は、ナルコレプシーのグローバル市場について調査・分析したレポートで、種類別（1型ナルコレプシー、2型ナルコレプシー）、用途別（病院、診療所、小売薬局）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。 ・ナルコレプシーの世界市場規模 ・主要企業別市場シェア ・ナルコレプシーの世界市場規模：種類別（1型ナルコレプシー、2型ナルコレプシー） ・ナルコレプシーの世界市場規模：用途別（病院、診療所、小売薬局） ・ナルコレプシーのアメリカ市場規模（種類別、用途別） ・ナルコレプシーのヨーロッパ市場規模（種類別、用途別） ・ナルコレプシーの中国市場規模（種類別、用途別） ・ナルコレプシーの日本市場規模（種類別、用途別） ・ナルコレプシーの東南アジア市場規模（種類別、用途別） ・ナルコレプシーのインド市場規模（種類別、用途別） ・ナルコレプシーの中南米市場規模（種類別、用途別） ・主要企業別分析（企業概要、製品動向、販売量など） ・ナルコレプシーの世界市場予測（2019年-2025年） ・ナルコレプシーの地域別市場予測（2019年-2025年） ... |
Narcolepsy is a neurological disorder that affects the control of sleep and wakefulness. People with narcolepsy experience excessive daytime sleepiness and intermittent, uncontrollable episodes of falling asleep during the daytime. These sudden sleep attacks may occur during any type of activity at any time of the day.People with narcolepsy can be substantially helped, but not cured. Treatment is tailored to the individual, based on symptoms and therapeutic response. The time required to achieve optimal control of symptoms is highly variable and may take several months or longer. Medication adjustments are frequently necessary, and complete control of symptoms is seldom possible. While oral medications are the mainstay of formal narcolepsy treatment, lifestyle changes are also important.
In 2018, the global Narcolepsy market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Narcolepsy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Narcolepsy development in United States, Europe and China.
The key players covered in this study
Jazz Pharmaceuticals
Bioprojet
Arena Pharmaceuticals
Graymark Healthcare
Mylan
Teva Pharmaceutical Industries
Novartis
Shire
Shionogi
Ligand Pharmaceuticals
Market segment by Type, the product can be split into
Type 1 Narcolepsy
Type 2 Narcolepsy
Market segment by Application, split into
Hospitals
Clinics
Retail Pharmacies
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Narcolepsy status, future forecast, growth opportunity, key market and key players.
To present the Narcolepsy development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Narcolepsy are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Narcolepsy Market Size Growth Rate by Type (2014-2025)
1.4.2 Type 1 Narcolepsy
1.4.3 Type 2 Narcolepsy
1.5 Market by Application
1.5.1 Global Narcolepsy Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Retail Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Narcolepsy Market Size
2.2 Narcolepsy Growth Trends by Regions
2.2.1 Narcolepsy Market Size by Regions (2014-2025)
2.2.2 Narcolepsy Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Narcolepsy Market Size by Manufacturers
3.1.1 Global Narcolepsy Revenue by Manufacturers (2014-2019)
3.1.2 Global Narcolepsy Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Narcolepsy Market Concentration Ratio (CR5 and HHI)
3.2 Narcolepsy Key Players Head office and Area Served
3.3 Key Players Narcolepsy Product/Solution/Service
3.4 Date of Enter into Narcolepsy Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Narcolepsy Market Size by Type (2014-2019)
4.2 Global Narcolepsy Market Size by Application (2014-2019)
5 United States
5.1 United States Narcolepsy Market Size (2014-2019)
5.2 Narcolepsy Key Players in United States
5.3 United States Narcolepsy Market Size by Type
5.4 United States Narcolepsy Market Size by Application
6 Europe
6.1 Europe Narcolepsy Market Size (2014-2019)
6.2 Narcolepsy Key Players in Europe
6.3 Europe Narcolepsy Market Size by Type
6.4 Europe Narcolepsy Market Size by Application
7 China
7.1 China Narcolepsy Market Size (2014-2019)
7.2 Narcolepsy Key Players in China
7.3 China Narcolepsy Market Size by Type
7.4 China Narcolepsy Market Size by Application
8 Japan
8.1 Japan Narcolepsy Market Size (2014-2019)
8.2 Narcolepsy Key Players in Japan
8.3 Japan Narcolepsy Market Size by Type
8.4 Japan Narcolepsy Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Narcolepsy Market Size (2014-2019)
9.2 Narcolepsy Key Players in Southeast Asia
9.3 Southeast Asia Narcolepsy Market Size by Type
9.4 Southeast Asia Narcolepsy Market Size by Application
10 India
10.1 India Narcolepsy Market Size (2014-2019)
10.2 Narcolepsy Key Players in India
10.3 India Narcolepsy Market Size by Type
10.4 India Narcolepsy Market Size by Application
11 Central & South America
11.1 Central & South America Narcolepsy Market Size (2014-2019)
11.2 Narcolepsy Key Players in Central & South America
11.3 Central & South America Narcolepsy Market Size by Type
11.4 Central & South America Narcolepsy Market Size by Application
12 International Players Profiles
12.1 Jazz Pharmaceuticals
12.1.1 Jazz Pharmaceuticals Company Details
12.1.2 Company Description and Business Overview
12.1.3 Narcolepsy Introduction
12.1.4 Jazz Pharmaceuticals Revenue in Narcolepsy Business (2014-2019)
12.1.5 Jazz Pharmaceuticals Recent Development
12.2 Bioprojet
12.2.1 Bioprojet Company Details
12.2.2 Company Description and Business Overview
12.2.3 Narcolepsy Introduction
12.2.4 Bioprojet Revenue in Narcolepsy Business (2014-2019)
12.2.5 Bioprojet Recent Development
12.3 Arena Pharmaceuticals
12.3.1 Arena Pharmaceuticals Company Details
12.3.2 Company Description and Business Overview
12.3.3 Narcolepsy Introduction
12.3.4 Arena Pharmaceuticals Revenue in Narcolepsy Business (2014-2019)
12.3.5 Arena Pharmaceuticals Recent Development
12.4 Graymark Healthcare
12.4.1 Graymark Healthcare Company Details
12.4.2 Company Description and Business Overview
12.4.3 Narcolepsy Introduction
12.4.4 Graymark Healthcare Revenue in Narcolepsy Business (2014-2019)
12.4.5 Graymark Healthcare Recent Development
12.5 Mylan
12.5.1 Mylan Company Details
12.5.2 Company Description and Business Overview
12.5.3 Narcolepsy Introduction
12.5.4 Mylan Revenue in Narcolepsy Business (2014-2019)
12.5.5 Mylan Recent Development
12.6 Teva Pharmaceutical Industries
12.6.1 Teva Pharmaceutical Industries Company Details
12.6.2 Company Description and Business Overview
12.6.3 Narcolepsy Introduction
12.6.4 Teva Pharmaceutical Industries Revenue in Narcolepsy Business (2014-2019)
12.6.5 Teva Pharmaceutical Industries Recent Development
12.7 Novartis
12.7.1 Novartis Company Details
12.7.2 Company Description and Business Overview
12.7.3 Narcolepsy Introduction
12.7.4 Novartis Revenue in Narcolepsy Business (2014-2019)
12.7.5 Novartis Recent Development
12.8 Shire
12.8.1 Shire Company Details
12.8.2 Company Description and Business Overview
12.8.3 Narcolepsy Introduction
12.8.4 Shire Revenue in Narcolepsy Business (2014-2019)
12.8.5 Shire Recent Development
12.9 Shionogi
12.9.1 Shionogi Company Details
12.9.2 Company Description and Business Overview
12.9.3 Narcolepsy Introduction
12.9.4 Shionogi Revenue in Narcolepsy Business (2014-2019)
12.9.5 Shionogi Recent Development
12.10 Ligand Pharmaceuticals
12.10.1 Ligand Pharmaceuticals Company Details
12.10.2 Company Description and Business Overview
12.10.3 Narcolepsy Introduction
12.10.4 Ligand Pharmaceuticals Revenue in Narcolepsy Business (2014-2019)
12.10.5 Ligand Pharmaceuticals Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Narcolepsy Key Market Segments
Table Key Players Narcolepsy Covered
Table Global Narcolepsy Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Narcolepsy Market Size Market Share by Type 2014-2025
Figure Type 1 Narcolepsy Figures
Table Key Players of Type 1 Narcolepsy
Figure Type 2 Narcolepsy Figures
Table Key Players of Type 2 Narcolepsy
Table Global Narcolepsy Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Retail Pharmacies Case Studies
Figure Narcolepsy Report Years Considered
Table Global Narcolepsy Market Size 2014-2025 (Million US$)
Figure Global Narcolepsy Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Narcolepsy Market Size by Regions 2014-2025 (Million US$)
Table Global Narcolepsy Market Size by Regions 2014-2019 (Million US$)
Table Global Narcolepsy Market Share by Regions 2014-2019
Figure Global Narcolepsy Market Share by Regions 2014-2019
Figure Global Narcolepsy Market Share by Regions 2019
Table Market Top Trends
Table Global Narcolepsy Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Narcolepsy Market Share by Manufacturers (2014-2019)
Figure Global Narcolepsy Market Share by Manufacturers in 2018
Table Global Narcolepsy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Narcolepsy Product/Solution/Service
Table Date of Enter into Narcolepsy Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Narcolepsy Market Size by Type (2014-2019) (Million US$)
Table Global Narcolepsy Market Size Share by Type (2014-2019)
Figure Global Narcolepsy Market Size Market Share by Type (2014-2019)
Table Global Narcolepsy Market Size by Application (2014-2019) (Million US$)
Table Global Narcolepsy Market Size Share by Application (2014-2019)
Figure Global Narcolepsy Market Size Market Share by Application (2014-2019)
Figure Global Narcolepsy Revenue Market Share by Application in 2018
Figure United States Narcolepsy Market Size 2014-2019 (Million US$)
Table United States Key Players Narcolepsy Revenue (2018-2019) (Million US$)
Table United States Key Players Narcolepsy Market Share (2018-2019)
Table United States Narcolepsy Market Size by Type (2014-2019) (Million US$)
Table United States Narcolepsy Market Share by Type (2014-2019)
Table United States Narcolepsy Market Size by Application (2014-2019) (Million US$)
Table United States Narcolepsy Market Share by Application (2014-2019)
Figure Europe Narcolepsy Market Size 2014-2019 (Million US$)
Table Europe Key Players Narcolepsy Revenue (2018-2019) (Million US$)
Table Europe Key Players Narcolepsy Market Share (2018-2019)
Table Europe Narcolepsy Market Size by Type (2014-2019) (Million US$)
Table Europe Narcolepsy Market Share by Type (2014-2019)
Table Europe Narcolepsy Market Size by Application (2014-2019) (Million US$)
Table Europe Narcolepsy Market Share by Application (2014-2019)
Figure China Narcolepsy Market Size 2014-2019 (Million US$)
Table China Key Players Narcolepsy Revenue (2018-2019) (Million US$)
Table China Key Players Narcolepsy Market Share (2018-2019)
Table China Narcolepsy Market Size by Type (2014-20189) (Million US$)
Table China Narcolepsy Market Share by Type (2014-2019)
Table China Narcolepsy Market Size by Application (2014-2019) (Million US$)
Table China Narcolepsy Market Share by Application (2014-2019)
Figure Japan Narcolepsy Market Size 2014-2019 (Million US$)
Table Japan Key Players Narcolepsy Revenue (2018-2019) (Million US$)
Table Japan Key Players Narcolepsy Market Share (2018-2019)
Table Japan Narcolepsy Market Size by Type (2014-2019) (Million US$)
Table Japan Narcolepsy Market Share by Type (2014-2019)
Table Japan Narcolepsy Market Size by Application (2014-2019) (Million US$)
Table Japan Narcolepsy Market Share by Application (2014-2019)
Figure Southeast Asia Narcolepsy Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Narcolepsy Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Narcolepsy Market Share (2018-2019)
Table Southeast Asia Narcolepsy Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Narcolepsy Market Share by Type (2014-2019)
Table Southeast Asia Narcolepsy Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Narcolepsy Market Share by Application (2014-2019)
Figure India Narcolepsy Market Size 2014-2019 (Million US$)
Table India Key Players Narcolepsy Revenue (2018-2019) (Million US$)
Table India Key Players Narcolepsy Market Share (2018-2019)
Table India Narcolepsy Market Size by Type (2014-2019) (Million US$)
Table India Narcolepsy Market Share by Type (2014-2019)
Table India Narcolepsy Market Size by Application (2014-2019) (Million US$)
Table India Narcolepsy Market Share by Application (2014-2019)
Figure Central & South America Narcolepsy Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Narcolepsy Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Narcolepsy Market Share (2018-2019)
Table Central & South America Narcolepsy Market Size by Type (2014-2019) (Million US$)
Table Central & South America Narcolepsy Market Share by Type (2014-2019)
Table Central & South America Narcolepsy Market Size by Application (2014-2019) (Million US$)
Table Central & South America Narcolepsy Market Share by Application (2014-2019)
Table Jazz Pharmaceuticals Company Details
Table Jazz Pharmaceuticals Revenue in Narcolepsy Business (2014-2019) (Million US$)
Figure Jazz Pharmaceuticals Revenue Growth Rate in Narcolepsy Business (2014-2019)
Table Jazz Pharmaceuticals Recent Development
Table Bioprojet Company Details
Table Bioprojet Revenue in Narcolepsy Business (2014-2019)(Million US$)
Figure Bioprojet Revenue Growth Rate in Narcolepsy Business (2014-2019)
Table Bioprojet Recent Development
Table Arena Pharmaceuticals Company Details
Table Arena Pharmaceuticals Revenue in Narcolepsy Business (2014-2019)(Million US$)
Figure Arena Pharmaceuticals Revenue Growth Rate in Narcolepsy Business (2014-2019)
Table Arena Pharmaceuticals Recent Development
Table Graymark Healthcare Company Details
Table Graymark Healthcare Revenue in Narcolepsy Business (2014-2019)(Million US$)
Figure Graymark Healthcare Revenue Growth Rate in Narcolepsy Business (2014-2019)
Table Graymark Healthcare Recent Development
Table Mylan Company Details
Table Mylan Revenue in Narcolepsy Business (2014-2019)(Million US$)
Figure Mylan Revenue Growth Rate in Narcolepsy Business (2014-2019)
Table Mylan Recent Development
Table Teva Pharmaceutical Industries Company Details
Table Teva Pharmaceutical Industries Revenue in Narcolepsy Business (2014-2019)(Million US$)
Figure Teva Pharmaceutical Industries Revenue Growth Rate in Narcolepsy Business (2014-2019)
Table Teva Pharmaceutical Industries Recent Development
Table Novartis Company Details
Table Novartis Revenue in Narcolepsy Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Narcolepsy Business (2014-2019)
Table Novartis Recent Development
Table Shire Company Details
Table Shire Revenue in Narcolepsy Business (2014-2019)(Million US$)
Figure Shire Revenue Growth Rate in Narcolepsy Business (2014-2019)
Table Shire Recent Development
Table Shionogi Company Details
Table Shionogi Revenue in Narcolepsy Business (2014-2019)(Million US$)
Figure Shionogi Revenue Growth Rate in Narcolepsy Business (2014-2019)
Table Shionogi Recent Development
Table Ligand Pharmaceuticals Company Details
Table Ligand Pharmaceuticals Revenue in Narcolepsy Business (2014-2019)(Million US$)
Figure Ligand Pharmaceuticals Revenue Growth Rate in Narcolepsy Business (2014-2019)
Table Ligand Pharmaceuticals Recent Development
Table Global Narcolepsy Market Size by Regions (Million US$) 2019-2025
Figure Global Narcolepsy Market Size Share by Regions (2019-2025)
Figure Global Narcolepsy Market Size Share by Regions in 2025
Figure United States Narcolepsy Market Size Forecast (2019-2025)(Million USD)
Figure Europe Narcolepsy Market Size Forecast (2019-2025)(Million USD)
Figure China Narcolepsy Market Size Forecast (2019-2025)(Million USD)
Figure Japan Narcolepsy Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Narcolepsy Market Size Forecast (2019-2025)(Million USD)
Figure India Narcolepsy Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Narcolepsy Market Size Forecast (2019-2025)(Million USD)
Table Global Narcolepsy Market Size by Product (2019-2025) (Million US$)
Figure Global Narcolepsy Market Size by Product (2019-2025)
Figure Global Narcolepsy Market Size by Product in 2025
Table Global Narcolepsy Market Size by Application (2019-2025) (Million US$)
Figure Global Narcolepsy Market Size by Application (2019-2025)
Figure Global Narcolepsy Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
世界の非カタプレキシーナルコレプシー薬市場：市場規模・現状・予測 In 2018, the global Non Cataplexy Narcolepsy Drugs market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025. This report focuses on the global Non Cataplexy Narcolepsy Drugs status, future forecast, growth opportunity, key market and key…- 世界のナルコレプシー治療市場：市場規模・現状・予測 Narcolepsy is a chronic neurological disorder that is associated with Excessive Daytime Sleepiness (EDS), hypnagogic hallucinations, cataplexy, sleep paralysis, and fragmented night sleep.By therapeutic treatment, the global narcolepsy treatment market is segmented into central nervous system stimul…
- 世界のデジタル小売市場：市場規模・現状・予測 Digital retailing should be a connected experience (or series of connected experiences) that allows consumers to understand each step in the shopping process. Consumers are in complete, 100% control over their journey and their destination.Digital transformation in retail is rapidly unfolding as com…
- 世界のクッシング病治療市場：市場規模・現状・予測 Cushing disease is caused by tumour in the pituitary gland which leads to excessive secretion of a hormone called adrenocorticotrophic (ACTH), which in turn leads to increasing levels of cortisol in the body. Cortisol is a steroid hormone released by the adrenal glands and helps the body to deal wit…
- 世界のオレキシン受容体2型市場2019 The global Orexin Receptor Type 2 market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Orexin Receptor Type 2 market status and forecast, categorizes the global Orexin Receptor Type 2 market size…